Uses:
The Cutaneous Adverse Drug Reaction Series (CAD-1000) contains chemicals and substances present in pharmaceutical products such as antibiotics, NSAID
The Cutaneous Adverse Drug Reaction Series (CAD-1000) contains chemicals and substances present in pharmaceutical products such as antibiotics, NSAID
| Art.No | Name | Conc | |
|---|---|---|---|
| 1. | C-054 | Cefixime trihydrate | 10.0% pet |
| 2. | A-030 | Amoxicillin trihydrate | 10.0% pet |
| 3. | D-058 | Dicloxacillin sodium salt hydrate | 10.0% pet |
| 4. | C-040 | Cefotaxim sodium salt | 10.0% pet |
| 5. | D-059 | Doxycycline monohydrate | 10.0% pet |
| 6. | C-055 | Cefpodoxime proxetil | 10.0% pet |
| 7. | E-024 | Erythromycin base | 10% pet |
| 8. | S-012 | Spiramycin base | 10.0% pet |
| 9. | C-041 | Clarithromycin | 10.0% pet |
| 10. | P-040 | Potassium clavulanate | 10.0% pet |
| 11. | C-042 | Cotrimoxazole | 10.0% pet |
| 12. | N-007 | Norfloxacin | 10.0% pet |
| 13. | C-043 | Ciprofloxacin hydrochloride | 10.0% pet |
| 14. | C-044 | Carbamazepine | 1.0% pet |
| 15. | H-027 | Hydantoin | 10.0% pet |
| 16. | D-060 | Diltiazem hydrochloride | 10.0% pet |
| 17. | C-045 | Captopril | 5.0% pet |
| 18. | A-031 | Acetylsalicylic acid | 10.0% pet |
| 19. | D-061B | Diclofenac sodium salt | 5.0% pet |
| 20. | K-002B | Ketoprofen | 1.0% pet |
| 21. | P-033 | Piroxicam | 1.0% pet |
| 22. | A-032 | ACETAMINOPHEN | 10.0% pet |
| 23. | A-033 | Acyclovir | 10.0% pet |
| 24. | H-028 | Hydroxyzine hydrochloride | 1.0% pet |
| 25. | H-029 | Hydrochlorothiazide discontinued as of 9th of August 2024 | 10.0% pet |
| 26. | C-046 | Clindamycin phosphate | 10.0% pet |
| 27. | C-047 | Cefradine | 10.0% pet |
| 28. | C-048 | Cefalexin | 10.0% pet |
| 29. | I-010A | Ibuprofen | 10.0% pet |
| 30. | L-009 | Lamotrigine | 10.0% pet |
| 31. | C-053 | Cefuroxime sodium | 10.0% pet |